SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.
Int J Mol Sci
; 18(5)2017 May 18.
Article
in En
| MEDLINE
| ID: mdl-28524098
Full text:
1
Database:
MEDLINE
Main subject:
Diabetic Nephropathies
/
Sodium-Glucose Transporter 2
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Year:
2017
Type:
Article